Thrivent Financial for Lutherans
REGN icon

Thrivent Financial for Lutherans’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.99M Sell
9,513
-128,777
-93% -$67.6M 0.01% 835
2025
Q1
$87.7M Buy
138,290
+13,096
+10% +$8.31M 0.19% 131
2024
Q4
$89.2M Buy
125,194
+116,074
+1,273% +$82.7M 0.17% 144
2024
Q3
$9.59M Buy
9,120
+1,306
+17% +$1.37M 0.02% 691
2024
Q2
$8.21M Sell
7,814
-32
-0.4% -$33.6K 0.02% 725
2024
Q1
$7.55M Sell
7,846
-2,153
-22% -$2.07M 0.02% 742
2023
Q4
$8.78M Sell
9,999
-3,571
-26% -$3.14M 0.02% 679
2023
Q3
$11.2M Sell
13,570
-75,985
-85% -$62.5M 0.03% 576
2023
Q2
$64.3M Sell
89,555
-23,772
-21% -$17.1M 0.15% 193
2023
Q1
$93.1M Sell
113,327
-52,791
-32% -$43.4M 0.23% 122
2022
Q4
$120M Buy
166,118
+7,793
+5% +$5.62M 0.31% 74
2022
Q3
$109M Buy
158,325
+34,912
+28% +$24M 0.3% 71
2022
Q2
$73M Buy
123,413
+102,809
+499% +$60.8M 0.19% 136
2022
Q1
$14.4M Sell
20,604
-32,380
-61% -$22.6M 0.03% 571
2021
Q4
$33.5M Sell
52,984
-2,015
-4% -$1.27M 0.06% 330
2021
Q3
$33.3M Sell
54,999
-200
-0.4% -$121K 0.07% 322
2021
Q2
$30.8M Buy
55,199
+16,546
+43% +$9.24M 0.06% 351
2021
Q1
$18.3M Sell
38,653
-19,419
-33% -$9.19M 0.04% 473
2020
Q4
$28.1M Buy
58,072
+14,013
+32% +$6.77M 0.06% 366
2020
Q3
$24.7M Sell
44,059
-1,035
-2% -$579K 0.07% 346
2020
Q2
$28.1M Buy
45,094
+41,453
+1,139% +$25.9M 0.08% 278
2020
Q1
$1.78M Hold
3,641
0.01% 1006
2019
Q4
$1.37M Buy
3,641
+12
+0.3% +$4.51K ﹤0.01% 1260
2019
Q3
$1.01M Buy
3,629
+98
+3% +$27.2K ﹤0.01% 1405
2019
Q2
$1.11M Buy
3,531
+31
+0.9% +$9.7K ﹤0.01% 1330
2019
Q1
$1.44M Buy
3,500
+119
+4% +$48.9K ﹤0.01% 1131
2018
Q4
$1.26M Buy
3,381
+59
+2% +$22K ﹤0.01% 1035
2018
Q3
$1.34M Buy
3,322
+74
+2% +$29.9K ﹤0.01% 1104
2018
Q2
$1.12M Buy
3,248
+34
+1% +$11.7K ﹤0.01% 1193
2018
Q1
$1.11M Buy
3,214
+85
+3% +$29.3K ﹤0.01% 1182
2017
Q4
$1.18M Buy
3,129
+109
+4% +$41K ﹤0.01% 1154
2017
Q3
$1.35M Buy
3,020
+170
+6% +$76K ﹤0.01% 1021
2017
Q2
$1.4M Buy
2,850
+60
+2% +$29.5K 0.01% 964
2017
Q1
$1.08M Buy
2,790
+170
+6% +$65.9K ﹤0.01% 1124
2016
Q4
$962K Buy
2,620
+160
+7% +$58.7K ﹤0.01% 1180
2016
Q3
$989K Sell
2,460
-2,020
-45% -$812K ﹤0.01% 1135
2016
Q2
$1.57M Buy
4,480
+110
+3% +$38.4K 0.01% 948
2016
Q1
$1.58M Buy
4,370
+2,150
+97% +$775K 0.01% 940
2015
Q4
$1.21M Buy
2,220
+170
+8% +$92.3K 0.01% 1008
2015
Q3
$954K Buy
2,050
+100
+5% +$46.5K 0.01% 977
2015
Q2
$995K Buy
1,950
+200
+11% +$102K 0.01% 830
2015
Q1
$790K Hold
1,750
﹤0.01% 920
2014
Q4
$718K Hold
1,750
﹤0.01% 948
2014
Q3
$631K Sell
1,750
-100
-5% -$36.1K ﹤0.01% 1005
2014
Q2
$523K Sell
1,850
-2,300
-55% -$650K ﹤0.01% 1111
2014
Q1
$1.25M Buy
4,150
+2,350
+131% +$706K 0.01% 683
2013
Q4
$495K Hold
1,800
﹤0.01% 995
2013
Q3
$563K Sell
1,800
-800
-31% -$250K ﹤0.01% 874
2013
Q2
$585 Buy
+2,600
New +$585 ﹤0.01% 853